Stockreport

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating 90% LDL-C reduction in non-human primates supports EDIT-401’s potential as a best-in-c [Read more]